Compare BXSL & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BXSL | STVN |
|---|---|---|
| Founded | 2018 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Containers/Packaging |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.2B |
| IPO Year | 2018 | 2021 |
| Metric | BXSL | STVN |
|---|---|---|
| Price | $23.59 | $19.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $24.66 | $24.47 |
| AVG Volume (30 Days) | ★ 1.4M | 281.8K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | ★ 13.18% | 0.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.96 |
| Revenue Next Year | N/A | $9.15 |
| P/E Ratio | $156.10 | ★ $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.47 | $12.89 |
| 52 Week High | $28.59 | $27.99 |
| Indicator | BXSL | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 44.69 | 37.85 |
| Support Level | $23.25 | $18.87 |
| Resistance Level | $25.00 | $20.02 |
| Average True Range (ATR) | 0.40 | 0.59 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 39.76 | 26.25 |
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.